A splice variant of cyclin D2 regulates cardiomyocyte cell cycle through a novel protein aggregation pathway

Qian Sun1, Feixiong Zhang, Karim Wafa

  • 1Department of Pharmacology, Sir Charles Tupper Medical Building, Dalhousie University, Halifax, NS, B3H 1X5 Canada.

Insights

A novel protein variant, cyclin D2 splice variant (D2SV), identified in mouse hearts, halts cardiomyocyte cell division. This discovery offers insights into preventing heart muscle regeneration by understanding cell cycle exit mechanisms.

Area of Science:

  • Cardiovascular Biology
  • Cell Cycle Regulation
  • Molecular Cardiology

Background:

  • Mammalian hearts have limited capacity for myocyte regeneration.
  • Mechanisms controlling cardiomyocyte cell cycle exit are poorly understood.

Purpose of the Study:

  • To investigate the role of a novel cyclin D2 splice variant (D2SV) in cardiomyocyte cell cycle exit.
  • To elucidate the molecular mechanisms underlying D2SV function in heart development and regeneration.

Main Methods:

  • Cloning and characterization of mouse D2SV.
  • Immunofluorescence and subcellular localization studies.
  • Analysis of protein-protein interactions and aggregation.
  • Manipulation of D2SV expression and cell cycle activity in cardiomyocytes.

Main Results:

  • D2SV is highly expressed in embryonic myocardium and decreases in adult hearts.
  • D2SV localizes to the endoplasmic reticulum, Golgi, and lysosomes, undergoing ER-stress-associated aggregation.
  • D2SV aggregation is dependent on dynein motor activity and modulated by ER stress.
  • D2SV sequesters other cell cycle proteins, promoting cell cycle exit.
  • Overexpression of D-type and B-type cyclins can rescue D2SV-induced cell cycle arrest.

Conclusions:

  • D2SV plays a critical role in cardiomyocyte cell cycle exit during development.
  • Protein aggregation of D2SV may represent a significant barrier to cardiomyocyte cell cycle reactivation and heart repair.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...